Sign in
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
Episode 112: Direct Perfluorocarbon-Silicone Oil Exchange with Dr. John Kitchens
Jayanth Sridhar, MD
Member Podcasts
2018
Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry
Jeremiah Brown, MD, MS, FASRS
Category: AMD-Neovascular